Nafziger, Anne N <br/><br/>
The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Oliceridine.  [electronic resource] 

 -  Clinical pharmacology in drug development  07 2020 
 - 639-650 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2160-7648 
<br/><br/><label>Standard No.: </label>10.1002/cpdd.750  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Pain--drug therapy<br/>Administration, Intravenous<br/>Adult<br/>Case-Control Studies<br/>Female<br/>Half-Life<br/>Healthy Volunteers<br/>Humans<br/>Kidney Failure, Chronic--complications<br/>Ligands<br/>Liver Diseases--complications<br/>Male<br/>Middle Aged<br/>Receptors, Opioid, mu--metabolism<br/>Safety<br/>Severity of Illness Index<br/>Spiro Compounds--administration & dosage<br/>Thiophenes--administration & dosage